Royce & Associates’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
CCM
CCA
Royce & Associates's THC Position: Q4 2022 in Review
Royce & Associates sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 243,335 shares — an estimated $12.6M sold.
Royce & Associates first reported a position in THC in Q2 2022 and held it in 2 quarters. The position peaked at $12.6M in Q3 2022. 354 funds tracked by Wall St. Rank hold THC as of Q4 2022.
- Royce & Associates reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
- Royce & Associates sold 243,335 Tenet Healthcare shares in Q4 2022, an estimated $12.6M.
- Royce & Associates first reported a position in Tenet Healthcare in Q2 2022 and held it in 2 quarters.
- Royce & Associates's Tenet Healthcare position peaked at $12.6M in Q3 2022.
- 354 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.
Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.